2026– date –
-
Lonza Unveils Enhanced DNA-to-IND Biologics Manufacturing Offering with 6-Month Timelines, Introducing GS Ori-Go™
PharmaSource Switzerland Overview Lonza has announced an enhanced 'DNA-to-IND' offering for biologics, aiming to achieve IND-readiness for monoclonal antibody programs in as little as six months. This accelerated timeline is supported by... -
Terumo Unveils ‘Ecosystem Blueprint’ to Scale Cell Therapies in Asia, Integrating Workflow, Equipment, and Training
Regen Report Japan Overview Terumo has introduced a new 'Ecosystem Blueprint' aimed at supporting the scaling of cell therapies in the Asia-Pacific region. This strategy seeks to transition cell therapies from early development to scalab... -
Fujifilm Diosynth Biotechnologies Strengthens Technological Leadership in Cell Culture, Microbial Fermentation, Viral Vectors, and Cell Therapy Manufacturing
MabDesign France Overview Fujifilm Diosynth Biotechnologies is focused on combining its technological leadership with cGMP manufacturing facilities across key areas: cell culture, microbial fermentation, viral vectors, and cell therapy. ... -
SelectScience Hosts Webinar on Microbial Ecosystem Response to Nutrient Changes, Featuring BioXplorer Platform
SelectScience UK Overview SelectScience will host a webinar titled 'Microbes in Motion Exploring Ecosystem Response to Nutrient Changes'. The BioXplorer platform offers automated environmental control, flexible feeding strategies, and in... -
Université Laval Announces Research Project on Predictive Modeling for Biomanufacturing Processes
Université Laval Canada Overview Université Laval has announced a research project focused on predictive modeling of biomanufacturing processes. Key themes include digital twins, machine learning, cell culture, proteins, bioreactors, and... -
Bioreactor Turndown Ratios in High-Density Perfusion Systems Revolutionize N-1 Perfusion Programs
Drug Discovery News USA Overview Optimizing bioreactor turndown ratios in high-density perfusion systems is revolutionizing N-1 perfusion programs. Bioreactors with turndown ratios of 10:1 or more enable both seed and production cultures... -
ENCell Secures US Clinical Manufacturing Contract for Ingenium’s AML-Targeting NK Cell Therapy, ‘gengleucel’
KBR South Korea Overview ENCell, a CDMO specializing in cell and gene therapies, has secured a manufacturing contract for Ingenium Therapeutics' allogeneic NK cell therapy candidate, 'gengleucel,' for U.S. clinical trials. This therapy t... -
Biosero Unveils Self-Correcting Bioprocessing Platform to Accelerate Pharma R&D Automation
Biosero USA Overview Biosero has introduced a self-correcting platform advancing bioprocessing automation in pharmaceutical R&D. Future systems are projected to adapt protocols in real-time based on process analytical data, learning ... -
US Policy Shift Reshapes Biomanufacturing Supply Chain: Fujifilm Diosynth, Japan Government Drive Asia’s Rise as Key Hub
BioProcess Insider USA Overview The U.S. policy pivot regarding China's biotechnology sector is driving a global biomanufacturing supply chain restructuring. Fujifilm Diosynth Biotechnologies is pursuing over $4 billion in global expansi... -
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ...
